Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Vaziri

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|February 5, 2008
DNA damage-induced ubiquitylation of RFC2 subunit of replication factor C complexJunya Tomida, Yuji Masuda, Hidekazu Hiroaki, et al.
NAR Cancer|January 21, 2026
Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis <i>in vivo</i>Jay R Anand, Bethany Wagner Brown, Jitong Lou, et al.
Genes & Cancer|March 16, 2023
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in <i>KRAS</i>-mutant pancreatic cancerYe S Lee, Jennifer E Klomp, Clint A Stalnecker, et al.
Journal of Medicinal Chemistry|September 12, 2025
Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4Jiwoong Lim, Lilly F Chiou, Brandon Novy, et al.
NAR Cancer|January 15, 2021
Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors <i>in vivo</i>Jitong Lou, Yang Yang, Qisheng Gu, et al.
NAR Cancer|March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stressJay R Anand, Gaith N Droby, Sayali Joseph, et al.
JCI Insight|January 23, 2026
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomasRebecca M Hirsch, Gaith Droby, Sunthoshini Premsankar, et al.
Scientific Reports|February 3, 2017
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cellsZheyong Liang, Wenjie Li, Jie Liu, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of its Canonical Roles in Ubiquitin SignalingLilly F Chiou, Deepika Jayaprakash, Gaith N Droby, et al.
The Journal of Biological Chemistry|September 14, 2016
Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) SubstrateKathleen M Mulvaney, Jacob P Matson, Priscila F Siesser, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|February 5, 2008
DNA damage-induced ubiquitylation of RFC2 subunit of replication factor C complexJunya Tomida, Yuji Masuda, Hidekazu Hiroaki, et al.
NAR Cancer|January 21, 2026
Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis <i>in vivo</i>Jay R Anand, Bethany Wagner Brown, Jitong Lou, et al.
Genes & Cancer|March 16, 2023
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in <i>KRAS</i>-mutant pancreatic cancerYe S Lee, Jennifer E Klomp, Clint A Stalnecker, et al.
Journal of Medicinal Chemistry|September 12, 2025
Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4Jiwoong Lim, Lilly F Chiou, Brandon Novy, et al.
NAR Cancer|January 15, 2021
Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors <i>in vivo</i>Jitong Lou, Yang Yang, Qisheng Gu, et al.
NAR Cancer|March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stressJay R Anand, Gaith N Droby, Sayali Joseph, et al.
JCI Insight|January 23, 2026
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomasRebecca M Hirsch, Gaith Droby, Sunthoshini Premsankar, et al.
Scientific Reports|February 3, 2017
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cellsZheyong Liang, Wenjie Li, Jie Liu, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of its Canonical Roles in Ubiquitin SignalingLilly F Chiou, Deepika Jayaprakash, Gaith N Droby, et al.
The Journal of Biological Chemistry|September 14, 2016
Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) SubstrateKathleen M Mulvaney, Jacob P Matson, Priscila F Siesser, et al.
Pageof 9